SBIR Phase I: Label Free Nucleic Acid Assays for POC Diagnostics

Phoenix Biosystems, Pleasanton CA

Investigators

Abstract

This Small Business Innovation Research (SBIR) Phase I project proposes to develop a Label Free Nucleic Acid Assay for Point-Of-Care (POC) Diagnostics especially for Sexually Transmitted Infections (STI). The broader impacts of this research are to enable effective diagnosis and treatment of chlamydia and gonorrhoeae in a single visit at the clinic and thus avoid patients who currently go untreated because they are lost-to-follow-ups. The ability to obtain easily available POC tests in primary care clinics, school clinics, Emergency Department settings, or even at-home testing (OTC), may have a far reaching impact on the rates of STIs in this country.